Loading provider…
Loading provider…
Ophthalmology Physician in Colton, CA
NPI: 1043412489Primary Practice Location
The Eye Surgery Center
1900 E Washington St, Colton, CA
Primary Employer
Pacific Eye Institute - Upland
pacificeyemd.com
HQ Phone
Get M.D. Richard's Phone Numberphone_androidMobile
Get M.D. Richard's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
2006 - 2025
NY State Medical License
2003 - 2005
CA State Medical License

American Board of Ophthalmology
Ophthalmology
NYU Grossman School of Medicine
med.nyu.edu
Residency • Ophthalmology
2003 - 2006
Johns Hopkins University
Internship • Internal Medicine
2002 - 2003
Sidney Kimmel Medical College
jefferson.edu
Medical School
Until 2002
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92134Diagnostic imaging of retina | 890 | 2,184 |
| 2 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 774 | 1,932 |
| 3 | 92202Extended examination of eye with drawing of optic nerve and surrounding area (macula) | 418 | 625 |
| 4 | 67028Injection of drug into eye | 312 | 1,119 |
| 5 | J9035Injection, bevacizumab, 10 mg | 172 | 594 |
Obliterative idiopathic juxtafoveolar telangiectasis: a 25-year follow-up.
Authors: Emmett Cunningham, H. Mcdonald, Robert Johnson, Everett Ai, Nikolas London, Robert Wong
Journal: Retin Cases Brief Rep
SOLITARY CIRCUMSCRIBED "PEARL WHITE" RETINAL MASS (SO-CALLED RETINAL ASTROCYTIC PROLIFERATION) RESIDES IN DEEP RETINA OR BENEATH RETINA: FINDINGS ON MULTIMODAL IMAGING IN 4 CASES.
Authors: Jerry Shields
Publication Date: 2016-01-12
Delayed fellow eye involvement in patients with Vogt–Koyanagi–Harada disease
Authors: Emmett Cunningham, H. Mcdonald, Robert Wong
Publication Date: 2009-05
Lead Sponsor: Hoffmann-La Roche
Intervention / Treatment: BIOLOGICAL: OpRegen